Which has the lower trailing P/E, ABT or GILD?

GILD has the lower trailing P/E: ABT trades at 33.60 and GILD at 17.78. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or GILD?

Over the past five years, GILD grew revenue faster — ABT at a 2.98% CAGR versus GILD at 3.07%.

Does ABT or GILD pay a bigger dividend?

ABT yields 2.34% and GILD yields 2.47% based on trailing dividends and the latest price.

Is ABT or GILD more profitable?

GILD runs the higher net margin — ABT at 11.65% versus GILD at 30.99%.

How have ABT and GILD total returns compared?

Over the past 10 years, ABT delivered 11.19% and GILD delivered 8.90% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Gilead Sciences, Inc. (GILD)

A side-by-side comparison of Abbott Laboratories and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$186.93B

$107.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

GILD

Gilead Sciences, Inc.

$166.77B

$134.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — ABT vs GILD

growth of $100 · dividends reinvested · last 30y

ABT +1921.4%GILD +32063.7%GILD compounded faster

Log scale — wide-divergence pair

ABT GILD

ABT vs GILD: by the numbers

•ABT is the larger company ($186.93B vs $166.77B market cap).
•GILD trades at the lower trailing earnings multiple (17.78 vs 33.60 P/E), one valuation lens rather than an overall verdict.
•GILD converts more revenue to profit (30.99% vs 11.65% net margin).
•GILD pays the higher dividend yield (2.47% vs 2.34%).

Metrics side by side

Valuation

Metric	ABT	GILD
P/E ratio	33.60	17.78
Forward P/E	18.96	N/A
P/S ratio	3.91	5.50
P/B ratio	3.51	6.96
PEG ratio	4.09	0.01
EV / EBITDA	21.21	12.61
FCF yield	4.04%	6.25%

Profitability

Metric	ABT	GILD
Gross margin	56.80%	79.35%
Operating margin	17.03%	38.26%
Net margin	11.65%	30.99%
ROE	10.42%	39.19%
ROIC	8.43%	21.53%

Dividends

Metric	ABT	GILD
Dividend yield	2.34%	2.47%
Payout ratio	65.24%	47.08%

Growth (annualized)

Metric	ABT	GILD
Revenue CAGR (5Y)	2.98%	3.07%
EPS CAGR (5Y)	8.22%	133.83%
FCF CAGR (5Y)	5.26%	3.30%
Total return CAGR (5Y)	-0.78%	18.02%

Frequently asked

Which has the lower trailing P/E, ABT or GILD?: GILD has the lower trailing P/E: ABT trades at 33.60 and GILD at 17.78. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or GILD?: Over the past five years, GILD grew revenue faster — ABT at a 2.98% CAGR versus GILD at 3.07%.
Does ABT or GILD pay a bigger dividend?: ABT yields 2.34% and GILD yields 2.47% based on trailing dividends and the latest price.
Is ABT or GILD more profitable?: GILD runs the higher net margin — ABT at 11.65% versus GILD at 30.99%.
How have ABT and GILD total returns compared?: Over the past 10 years, ABT delivered 11.19% and GILD delivered 8.90% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Gilead Sciences P/E ratio Abbott Laboratories dividend yield Gilead Sciences dividend yield Abbott Laboratories ROE Gilead Sciences ROE Abbott Laboratories operating margin Gilead Sciences operating margin Abbott Laboratories revenue growth Gilead Sciences revenue growth Abbott Laboratories free cash flow Gilead Sciences free cash flow

Abbott Laboratories & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.